Trial intelligence / Profile preview

Topical aloe vera gel plus urea cream vs urea cream alone to prevent hand-foot syndrome in capecitabine-treated cancer patients

TCTR20230411005Phase 2Completed

Sponsor
Navamindradhiraj University Research Fund
Start
Dec 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of capecitabine in Erythrodysesthesia syndrome (PPE), sponsored by Navamindradhiraj University Research Fund. Started Dec 2021; status: completed.

02

Drugs

capecitabine
03

Conditions

Erythrodysesthesia syndrome (PPE)

Beyond the preview

Go deeper on TCTR20230411005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230411005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call